Athira Pharma, Inc. — Director's Dealing 2024

Apr 16, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Athira Pharma, Inc. (ATHA)
CIK: 0001620463
Period of Report: 2024-04-15

Reporting Person: San Martin Javier (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-04-15	Stock Option (Right to Buy)	$2.06	A	400000	Acquired	2034-04-14	Common Stock (400000)	Direct

Footnotes

F1: Twenty-five percent (25%) of the shares subject to the option will vest on the one (1) year anniversary of the date of grant, and one forty-eighth (1/48th) of the shares subject to the option will vest each month thereafter, subject to the optionee continuing to be a Service
Provider (as defined in the Issuer's 2024 Inducement Equity Incentive Plan) through the applicable vesting dates.